Monopar Therapeutics, Inc. (MNPR)
70.65
-1.93
(-2.66%)
USD |
NASDAQ |
Oct 23, 16:00
71.89
+1.24
(+1.76%)
After-Hours: 20:00
Monopar Therapeutics EPS Diluted (Quarterly) : -0.622 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.622 |
| March 31, 2026 | -0.4561 |
| December 31, 2025 | -0.7772 |
| September 30, 2025 | -0.4826 |
| June 30, 2025 | -0.3506 |
| March 31, 2025 | -0.3757 |
| December 31, 2024 | -2.23 |
| September 30, 2024 | -0.3705 |
| June 30, 2024 | -0.4897 |
| March 31, 2024 | -0.5135 |
| December 31, 2023 | -0.6085 |
| September 30, 2023 | -0.6919 |
| June 30, 2023 | -0.8196 |
| March 31, 2023 | -0.9288 |
| December 31, 2022 | -1.119 |
| September 30, 2022 | -0.9407 |
| June 30, 2022 | -1.094 |
| March 31, 2022 | -0.9746 |
| December 31, 2021 | -1.064 |
| September 30, 2021 | -0.9769 |
| Date | Value |
|---|---|
| June 30, 2021 | -0.8274 |
| March 31, 2021 | -0.776 |
| December 31, 2020 | -0.9292 |
| September 30, 2020 | -0.7374 |
| June 30, 2020 | -0.6789 |
| March 31, 2020 | -0.5134 |
| December 31, 2019 | -0.57 |
| September 30, 2019 | -0.3476 |
| June 30, 2019 | -0.4277 |
| March 31, 2019 | -0.65 |
| December 31, 2018 | -0.4205 |
| September 30, 2018 | -0.3024 |
| June 30, 2018 | -0.3877 |
| March 31, 2018 | -0.4138 |
| December 31, 2017 | -0.337 |
| September 30, 2017 | -7.026 |
| June 30, 2017 | -0.2793 |
| March 31, 2017 | -0.1761 |
| December 31, 2016 | -0.1514 |
| September 30, 2016 | -0.0912 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 4.366 |
| Anika Therapeutics, Inc. | 0.2412 |
| BioCryst Pharmaceuticals, Inc. | 0.2957 |
| Imunon, Inc. | -0.5412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.313M |
| Total Expenses (Quarterly) | 5.313M |
| Enterprise Value | 340.03M |
| Earnings Yield | -3.31% |
| Normalized Earnings Yield | -3.309 |